Abstract
The objective of this study is to report trends in mortality, as certified on death certificates, from multiple sclerosis (MS), motor neuron disease (MND), primary Parkinson’s disease (PD), and epilepsy, analysing not only the underlying cause of death but also all certified causes for each disease. Death records in the Oxford region, 1979–2006, and England, 1996–2006, were analysed for ascertaining the trends in mortality. The percentage of deaths coded as the underlying cause changed over time, coinciding with changes to the rules for selecting the underlying cause of death. Changes over time to coding rules had a large impact on apparent trends in death rates for PD when studied by underlying cause alone. They also had significant, though smaller, effects on trends in death rates for MS, MND and epilepsy. Nationally, in the last period of the study, underlying cause mortality identified 64% of deaths with a mention of MS, 88% of MND, 56% of PD, and 48% of epilepsy. In the longstanding Oxford data from 1979 to 2006, death rates based on all certified causes of death showed no significant change for MS; an upward trend for MND (notably in women over 75), though only in the last few years of the study; a significant but small decline for PD; and no significant change for epilepsy. When mortality statistics are analysed by underlying cause only, their value is reduced. A substantial percentage of neurological deaths are missed. Time trends may be misleading. All certified causes for each disease, as well as the underlying cause, should be analysed.
References
Bell GS, Gaitatzis A, Johnson AL et al (2004) Predictive value of death certification in the case ascertainment of epilepsy. J Neurol Neurosurg Psychiatry 75:1756–1758
Ben-Shlomo Y, Whitehead AS, Davey Smith G (1996) Parkinson’s, Alzheimer’s, and motor neurone disease. BMJ 312:724
Bruce M, Griffiths C, Brock A et al (2004) Trends in mortality and hospital admissions associated with epilepsy during the 1990s. Health Stat Q 21:23–29
Chancellor AM, Swingler RJ, Fraser H et al (1993) Utility of Scottish morbidity and mortality data for epidemiological studies of motor neuron disease. J Epidemiol Community Health 47:116–120
Chancellor AM, Hendry A, Caird FI et al (1993) Motor neuron disease: a disease of old age. Scott Med J 38:178–182
Coyle HP, Baker-Brian N, Brown SW (1994) Coroners’ autopsy reporting of sudden unexplained death in epilepsy (SUDEP) in the UK. Seizure 3:247–254
Day TG, Scott M, Perring R et al (2007) Motor neuron disease mortality in Great Britain continues to rise: examination of mortality rates 1975–2004. Amyotroph Lateral Scler 8:337–342
Dean G, Quigley M, Goldacre M (1994) Motor neuron disease in a defined English population: estimates of incidence and mortality. J Neurol Neurosurg Psychiatry 57:450–454
Forbes RB, Colville S, Cran GW et al (2004) Unexpected decline in survival from amyotrophic lateral sclerosis/motor neurone disease. J Neurol Neurosurg Psychiatry 75:1753–1755
Goldacre MJ (1993) Cause-specific mortality: understanding uncertain tips of the disease iceberg. J Epidemiol Community Health 47:491–496
Goldacre MJ, Duncan ME, Cook-Mozaffari P et al (2003) Trends in mortality rates comparing underlying-cause and multiple-cause coding in an English population 1979–1998. J Public Health Med 25:249–253
Goldacre MJ, Duncan ME, Griffith M et al (2006) Psychiatric disorders certified on death certificates in an English population. Soc Psychiatry Psychiatr Epidemiol 41:409–414
Griffiths C, Rooney C (2006) Trends in mortality from Alzheimer’s disease, Parkinson’s disease and dementia, England and Wales, 1979–2004. Health Stat Q 30:6–14
Hanna NJ, Black M, Sander JW et al (2002) The national sentinel clinical audit of epilepsy-related death: epilepsy death in the shadows. The Stationery Office, London
Li TM, Swash M, Alberman E (1985) Morbidity and mortality in motor neuron disease: comparison with multiple sclerosis and Parkinson’s disease: age and sex specific rates and cohort analyses. J Neurol Neurosurg Psychiatry 48:320–327
Li TM, Alberman E, Swash M (1990) Clinical features and associations of 560 cases of motor neuron disease. J Neurol Neurosurg Psychiatry 53:1043–1045
Noonan CW, White MC, Thurman D et al (2005) Temporal and geographic variation in United States motor neuron disease mortality, 1969–1998. Neurology 64:1215–1221
O’Callaghan FJ, Osmon C, Martyn CN (2000) Trends in epilepsy mortality in England and Wales and the United States, 1950–1994. Am J Epidemiol 151:182–189
Office of Population Censuses and Surveys (1985) Mortality statistics. Cause 1984. Series DH2 (11), HMSO London, v–ix
Office for National Statistics (1996) Mortality statistics. Cause 1993 (revised) and 1994. Series DH2 (21), HMSO, London, xxv–xxxiii
Office for National Statistics (2002) Mortality Statistics. Cause 2001. Series DH2 (28), ONS, London, pp 282–291
Phillips NJ, Reay J, Martyn CN (1999) Validity of mortality data for Parkinson’s disease. J Epidemiol Community Health 53:587–588
Redelings MD, McCoy L, Sorvillo F (2006) Multiple sclerosis mortality and patterns of comorbidity in the United States from 1990 to 2001. Neuroepidemiology 26:102–107
Rooney C, Devis T (1996) Mortality trends by cause of death in England and Wales 1980–94; the impact of introducing automated cause coding and related changes in 1993. Popul Trends 86:29–35
Sejvar JJ, Holman RC, Bresee JS et al (2005) Amyotrophic lateral sclerosis mortality in the United States, 1979–2001. Neuroepidemiology 25:144–152
Traynor BJ, Codd MB, Corr B et al (1999) Incidence and prevalence of ALS in Ireland, 1995–1997: a population-based study. Neurology 52:504–509
Traynor BJ, Alexander M, Corr B et al (2003) Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996–2000. J Neurol Neurosurg Psychiatry 74:1258–1261
Turner M, Bakker M, Sham P et al (2002) Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis. Amyotrophic Lateral Scler Other Motor Neuron Disord 3:15–21
Warren S, Warren KG, Svenson LW et al (2003) Geographic and temporal distribution of mortality rates for multiple sclerosis in Canada, 1965–1994. Neuroepidemiology 22:75–81
Williams ES, Jones DR, McKeran RO (1991) Mortality rates from multiple sclerosis: geographical and temporal variations revisited. J Neurol Neurosurg Psychiatry 54:104–109
World Health Organisation (1977) Manual of the statistical international classification of diseases, injuries, and causes of death. Ninth Revision, vol 1. World Health Organisation, Geneva, pp 699–763
World Health Organisation (1993) International statistical classification of diseases and related health problems. Tenth Revision, vol 2. World Health Organisation, Geneva, pp 30–88
Worms PM (2001) The epidemiology of motor neuron diseases: a review of recent studies. J Neurol Sci 191:3–9
Acknowledgments
The Unit of Health-Care Epidemiology is funded by the English NIHR Coordinating Centre for Research Capacity Development. MRT is supported through the MRC/MNDA Lady Edith Wolfson Clinician Scientist Fellowship.
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Goldacre, M.J., Duncan, M., Griffith, M. et al. Trends in death certification for multiple sclerosis, motor neuron disease, Parkinson’s disease and epilepsy in English populations 1979–2006. J Neurol 257, 706–715 (2010). https://doi.org/10.1007/s00415-009-5392-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-009-5392-z